Penumbra
PEN
#1771
Rank
A$14.77 B
Marketcap
$385.03
Share price
-0.08%
Change (1 day)
0.86%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Net assets

Net assets on the balance sheet as of September 2024 : A$1.76 Billion

According to Penumbra's latest financial reports the company has A$1.76 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Penumbra - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$1.73 B17.89%
2022-12-31$A$1.46 B11.88%
2021-12-31$A$1.31 B58.51%
2020-12-31$A$0.82 B19.81%
2019-12-31$A$0.69 B15.25%
2018-12-31$A$0.59 B16.87%
2017-12-31$A$0.51 B38.7%
2016-12-31$A$0.36 B15.84%
2015-12-31$A$0.31 B-2216.1%
2014-12-31$-A$15.09 Million66.9%
2013-12-31$-A$9.04 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$0.69 B-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.11 B 19.84%๐Ÿ‡บ๐Ÿ‡ธ USA